According to Biomerica's latest financial reports the company's current EPS (TTM) is -$0.47. In 2022 the company made an earnings per share (EPS) of -$0.43 an increase over its 2021 EPS that were of -$0.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.47 | 9.3% |
2022 | -$0.43 | -17.31% |
2021 | -$0.52 | 10.64% |
2020 | -$0.47 | 88% |
2019 | -$0.25 | 13.64% |
2018 | -$0.22 | 69.23% |
2017 | -$0.13 | -38.1% |
2016 | -$0.21 | |
2015 | N/A | -100% |
2014 | -$0.03640 | -27.2% |
2013 | -$0.05000 | -145.45% |
2012 | $0.11 | 57.14% |
2011 | $0.07000 | -800% |
2010 | -$0.010000 | -0% |
2009 | -$0.01000 | -107.69% |
2008 | $0.13 | -40.91% |
2007 | $0.22 | 266.67% |
2006 | $0.06000 | -0% |
2005 | $0.06000 | |
2004 | N/A | -100% |
2003 | -$0.04000 | -24.53% |
2002 | -$0.05300 | -83.94% |
2001 | -$0.33 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $4.73 | -1,106.38% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | -$1.00 | 112.77% | ๐บ๐ธ USA |
Biolase
BIOL | -$264.93 | 56,268.09% | ๐บ๐ธ USA |